BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31897351)

  • 1. Radiologic Contrast Media Desensitization for Delayed Cardiac Catheterization.
    Sanan N; Rowane M; Hostoffer R
    Allergy Rhinol (Providence); 2019; 10():2152656719892844. PubMed ID: 31897351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of anaphylactoid reactions in high-risk patients receiving radiographic contrast media.
    Wittbrodt ET; Spinler SA
    Ann Pharmacother; 1994 Feb; 28(2):236-41. PubMed ID: 8173143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferior vena cava assessment can predict contrast-induced nephropathy in patients undergoing cardiac catheterization: A single-center prospective study.
    Gungoren F; Besli F; Tanriverdi Z; Demirbag R
    Echocardiography; 2018 Dec; 35(12):1915-1921. PubMed ID: 30303247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe anaphylactoid reaction to radiographic contrast media. Recurrences despites premedication with diphenhydramine and prednisone.
    Madowitz JS; Schweiger MJ
    JAMA; 1979 Jun; 241(26):2813-5. PubMed ID: 448843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of radiographic contrast media in high-risk patients.
    Greenberger P; Patterson R; Kelly J; Stevenson DD; Simon D; Lieberman P
    Invest Radiol; 1980; 15(6 Suppl):S40-3. PubMed ID: 7203947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hydrocortisone desensitization in a patient with radiocontrast-induced anaphylactoid reaction and corticosteroid allergy.
    Lee-Wong M; McClelland S; Chong K; Fernandez-Perez ER
    Allergy Asthma Proc; 2006; 27(3):265-8. PubMed ID: 16913271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Nicorandil effectively attenuates the incidence of contrast-induced nephropathy in patients undergoing cardiac catheterization: a randomized, controlled, open-label clinical trial.
    Abdollahi Moghaddam A; Baradaran Rahimi V; Morovatdar N; Rezaee R; Babalhekam SA
    Int Urol Nephrol; 2023 Sep; 55(9):2327-2334. PubMed ID: 36881267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced nephropathy is associated with new-onset atrial fibrillation in acute coronary syndrome after cardiac catheterization: Systemic review and meta-analysis.
    Prasitlumkum N; Kanitsoraphan C; Kittipibul V; Poonsombudlert K; Limpruttidham N; Rattanawong P; Chongsathidkiet P
    Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12625. PubMed ID: 30615229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
    Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
    J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Desensitization to Overcome Contrast Allergy Prior to Urgent Coronary Angiography.
    Uppal S; DeCicco AE; Intini A; Josephson RA
    Int Heart J; 2018 May; 59(3):622-625. PubMed ID: 29628477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
    Sato A; Aonuma K; Watanabe M; Hirayama A; Tamaki N; Tsutsui H; Toyoaki M; Ogawa H; Akasaka T; Yoshimura M; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K; Saito Y;
    Int J Cardiol; 2017 Jan; 227():424-429. PubMed ID: 27838134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.
    Gao YM; Li D; Cheng H; Chen YP
    Clin Exp Nephrol; 2014 Dec; 18(6):892-8. PubMed ID: 24515307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic contrast media-induced noncardiogenic pulmonary edema: case report and review of the literature.
    Borish L; Matloff SM; Findlay SR
    J Allergy Clin Immunol; 1984 Jul; 74(1):104-7. PubMed ID: 6376598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic anaphylactoid reactions to iodinated contrast media during cardiac catheterization procedures: guidelines for prevention, diagnosis, and treatment. Laboratory Performance Standards Committee of the Society for Cardiac Angiography and Interventions.
    Goss JE; Chambers CE; Heupler FA
    Cathet Cardiovasc Diagn; 1995 Feb; 34(2):99-104; discussion 105. PubMed ID: 7788704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
    Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
    Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.